Eisai’s “ URECE(R)” (Dotinurad) Approved in China for Gout Patients with Hyperuricemia

TOKYO, Dec 11, 2024 – (JCN Newswire via SeaPRwire.com) – Eisai Co., Ltd. announced today that it has received approval for “URECE®” (brand name...